Fortrea Holdings Inc. Share Price

Fortrea Holdings Inc. Share Price

NASDAQ: FTRE | Small Cap
$21.28
-$1.89 (-8.16%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Fortrea Holdings Inc. Stock Performance

Open
$23.21
Prev. Close
$23.17
Circuit Range
N/A
Day Range
$20.70 - $23.40
Year Range
$8.57 - $26.08
Volume
2,49,139
Average Traded
$21.25

Fortrea Holdings Inc. Share Price Today

As of 31 October 2026, Fortrea Holdings Inc.'s share price is $21.28. The stock opened at $23.21, compared to its previous close of $23.17. During today's trading session, Fortrea Holdings Inc.'s share price traded between $20.70 and $23.40, with an average price of $22.05. Over the past 52 weeks, the stock has recorded a high of $26.08 and a low of $8.57. In terms of performance, Fortrea Holdings Inc.'s share price has risen by 85.04% over the last six months and is up 103.44% on a year-on-year basis.

Fortrea Holdings Inc. Share Price Chart

Line chart of the Fortrea Holdings Inc. price trend over the selected period. The price fell overall, ranging from 20.72 to 21.52, ending at 21.31.
$20.70$23.40
L
Show Current Price
H

Fortrea Holdings Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.94B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.71
Revenue (TTM)
$2.72T
Return On Equity (TTM)
-12.91%
Profit Margin
-36.21%
Debt to Equity
1.98
Quarterly Earnings Growth YoY
16.98%

Fortrea Holdings Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$701.30$660.50$636.50$678.20
Net Profit-$15.90-$32.50-$23.60-$13.20
Net Profit Margin-2.27%-4.92%-3.71%-1.95%
Income ChangeN/A-104.40%27.38%44.07%

Fortrea Holdings Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$2842.50$2696.40$2723.40
Net Profit-$25.20-$328.50-$986.20
Net Profit Margin-0.89%-12.18%-36.21%
Income ChangeN/A-1203.57%-200.21%

About Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

Fortrea Holdings Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$19.76
$21.41
+7.13%
Sep 2026
$18.39
$19.98
+5.97%
Aug 2026
$19.07
$18.86
-1.57%
Jul 2026
$17.73
$19.16
+10.08%
Jun 2026
$14.80
$17.41
+13.17%
May 2026
$11.69
$15.38
+33.74%
Apr 2026
$9.43
$11.50
+22.21%
Mar 2026
$10.54
$9.41
-12.18%
Feb 2026
$16.52
$10.71
-36.26%
Jan 2026
$17.17
$16.81
-2.58%
Dec 2025
$12.44
$17.25
+35.65%
Nov 2025
$10.52
$12.72
+21.61%

FTRE Share Price FAQs